Rankings
▼
Calendar
ANIK FY 2016 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$208M
FY 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$103M
+11.2% YoY
Gross Profit
$79M
76.8% margin
Operating Income
$51M
49.0% margin
Net Income
$33M
31.5% margin
EPS (Diluted)
$2.15
Cash Flow
Operating Cash Flow
$24M
Free Cash Flow
$10M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$240M
Total Liabilities
$17M
Stockholders' Equity
$223M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$103M
$93M
+11.2%
Gross Profit
$79M
$72M
+10.3%
Operating Income
$51M
$48M
+5.1%
Net Income
$33M
$31M
+5.8%
← FY 2015
All Quarters
Q1 2016 →